NCT00236041 2014-05-09Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)Teva Branded Pharmaceutical Products R&D, Inc.Phase 2 Completed38 enrolled